BMS ‘Increasingly Confident’ It Can Handle The Impact Of Medicare Pricing For Eliquis

Pharma To Announce IRA-Mandated Final Price Soon

 
• By Mandy Jackson
  
MUNICH, GERMANY - 5. July 2024: Bristol Myers Squibb logo sign of the biopharmaceutical company.
BMS raised its 2024 revenue guidance based on its Q2 performance • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Drug Pricing

More from Scrip